For professional laboratory research only
Tesamorelin Pen
Tesamorelin is a synthetic GHRH analogue for research into pituitary signalling and the growth hormone axis. Available in pen format (10 MG). For laboratory research only.
Documentation
Report available
Price per item
€ 114,95 incl. VAT
Free shipping on orders over €100.
Shipping and returns · Available delivery options are shown at checkout.
About Tesamorelin Pen
This format is offered as a research pen, with 10 MG as the stated strength. The pen format requires its own information about the device and contents. The quantity in milligrams does not by itself establish the liquid volume, a concentration or the amount dispensed per setting.
What is Tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, abbreviated GHRH. The substance is being investigated in relation to the GHRH receptor and signalling from the pituitary gland.
Tesamorelin is a different research material than a combination with ipamorelin. This Novogin listing concerns tesamorelin as a standalone product. To assess a blend, its own components and proportions are always required.
What does the research focus on?
The area of research includes receptor activation and the resulting endocrine signals. That context does not substantiate a medical application of this format.
- GHRH receptor-related signalling.
- Pituitary response and the growth hormone axis.
- IGF-related biomarkers in appropriate research models.
Research references
External sources describe the substance or research area; they do not certify this Novogin product, format or batch.
For laboratory and analytical research only. Not for use in humans or animals, consumption, cosmetic use or use as a food supplement. This research material is not offered as an approved medicine. No medical, dosing or injection advice is provided.
Product specifications
| Product | Tesamorelin Pen |
|---|---|
| Format | Research pen |
| Stated strength | 10 MG |
| Research area | Growth hormone research |
| Storage | According to the current batch documentation |
| Intended use | Laboratory and analytical research |
Using this research pen
Use this product only within a validated laboratory workflow and after consulting the manufacturer's current operating instructions. The public product information does not establish fill volume, concentration, dispensing increment, accuracy, sterility, stability or cartridge compatibility.
- Check the selected strength, compound identity and batch before starting the experiment.
- Consult the current operating instructions, safety data sheet and batch documentation.
- Validate device, cartridge and solvent compatibility, as well as dispensing accuracy for the selected method.
- Document preparation, storage, handling, cleaning and disposal within the laboratory workflow.
Do not use instructions written for an authorised medicine pen with this research pen.
| Strength | 10 MG |
|---|---|
| COA status | Not publicly listed |
Frequently asked questions
Does this product contain ipamorelin?
The Novogin entry concerns Tesamorelin. No Tesamorelin + Ipamorelin blend has been specified as a composition for this article.
What purity does the vial report state?
Report #211783, batch 2601628, states a purity of 96.709% for the tested sample. The report is linked as substance documentation for Tesamorelin vial and pen. The sample value is not a general purity guarantee for every delivered format.
Is the pen the same format as the vial?
Tesamorelin Pen is a separate product format that can share substance documentation with the vial. Device compatibility, retail content and the link to the delivered batch must be assessed separately for the pen.
How should I store this product?
Follow the current storage information for the supplied batch and product format. Do not use a general storage temperature or shelf life from a comparable product as a substitute for its own documentation.
Batch & documentation
| Report number | 211783 |
|---|---|
| Laboratory | Janoshik |
| Analysis date | 2026-07-31 |
| Sample label | 10 mg |
| Format | Vial |
| Measured content | 9.20 mg |
| Purity | 96.709% |
| Documentation coverage | Linked products of the same substance, including their strength variants |
| Stock link for sampled variant | Current stock not confirmed |
| Documentation batch | 2601628 |
Measurements describe the tested sample. Documentation coverage does not automatically confirm the sale contents, device characteristics or supplied batch of every format. Check these separately.
